CLEARWATER - Apyx Medical Corporation (Nasdaq: APYX) ('Apyx Medical;' the 'Company'), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery's 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 - 24.

'Apyx Medical is pleased to see Renuvion featured in a variety of insightful educational presentations during AACS 2024, which we believe will help to expand the awareness of our Helium Plasma Technology and its benefits,' said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical. 'We look forward to the presentation by Dr. Michael Kluska, featuring the results of a new retrospective clinical study that demonstrates the strong safety profile of Renuvion following liposuction and body contouring procedures, when compared to a competing technology. We welcome this addition to the compelling body of clinical and evidence-based medicine supporting the safety and efficacy of Renuvion when used for cosmetic surgery procedures.'

Renuvion will be discussed in presentations during the following educational sessions: Pearls & Pitfalls of Ultrasound Guided Gluteal Fat Transfer presented by Giselle Prado-Wright, MD, MBA Session 12 (Ultrasound-Guided Brazilian Butt Lift), Thursday, February 22, 2024, 4:00 p.m. Eastern Time

Excisional vs. Minimally Invasive Interventions for Loose Skin presented by Giselle Prado-Wright, MD, MBA; Session 33 (Abdominoplasty & Body Contouring); Saturday, February 24, 2024, 11:00 a.m. Eastern Time

A Contiguous Series Retrospective Review of Patient Charts where Renuvion was used for Body Contouring Compared to the InMode RF System presented by Michael Kluska, DO, FAACS, FACOS; Session 38 (Adjuncts for Total Patient Care); Saturday, February 24, 2024, 1:30 p.m. Eastern Time

The presentation by Dr. Michael Kluska will feature the results of a retrospective clinical study conducted by Kluska et al. The study evaluated retrospective procedure and safety data to compare Renuvion's Helium Plasma Technology to InMode's Bipolar RF System when used in conjunction with liposuction or body contouring. Demographic, procedure and safety data were collected and evaluated from a contiguous series of more than 450 patients, including 229 patients treated with Renuvion and 236 patients treated with Bipolar RF. The researchers analyzed adverse events recorded by the body area during or post-procedure for each group. They found a statistically significant difference in the number of reported adverse events between these two patient groups (p-value

(C) 2024 Electronic News Publishing, source ENP Newswire